Prostate Cancer News - 2017-05
General News
About prostate cancer research, cases and public awareness:- PodMed: A Medical News Roundup From Johns Hopkins | Medpage Today
- Historic Victory for Prostate Cancer: Congress Adds $10 Million for Research Program — BioPortfolio.com
- A piece of good news from Washington, DC | THE "NEW" PROSTATE CANCER INFOLINK
- Research Concludes Clinical Intervention of Molecular Targeted Therapy In Cancer Treatment — BioPortfolio.com
- Prostatepedia Weekly
Case Management
Planning a campaign against prostate cancer:- What It’s Like to Be Part of a Prostate Cancer Support Group - Future of Personal Health
- Studies Highlight Shifts in Prostate Cancer Screening and Management — BioPortfolio.com
- More on the new guidelines for treatment of localized prostate cancer | THE "NEW" PROSTATE CANCER INFOLINK
- New guidance on treatment of localized prostate cancer from AUA and others | THE "NEW" PROSTATE CANCER INFOLINK
- Diagnosis, Staging, and Risk Stratification in Prostate Cancer: Utilizing Diagnostic Tools to Avoid Unnecessary Therapies and Side Effects: Cancer Biology & Therapy: Vol 0, No ja
Life Choices
can influence the odds in your favor:Diet
can starve the cancer- Expanding Waistlines and Link to Metabolic Syndrome | Cooking with Kathy Man
- Access : Increased dietary and circulating lycopene are associated with reduced prostate cancer risk: a systematic review and meta-analysis : Prostate Cancer and Prostatic Diseases
Exercise
can give you strength to fight the cancer and treatment side effects
- Yoga Benefits Prostate Cancer Patients By Reducing Radiation Treatment Side Effects - Dr. David Samadi — BioPortfolio.com
- It's Yoga to the Rescue for Prostate Cancer Patients
Screening and Diagnosis
early detection is important because symptoms appear too late for treatment:- We Undergo PSA Testing Ourselves, Say Urologists
- Prostate Health Index for Prostate Cancer Diagnosis
- Access : Unscreened older men diagnosed with prostate cancer are at increased risk of aggressive disease : Prostate Cancer and Prostatic Diseases
- Black men must face the truth about prostate cancer | Linford Christie | Opinion | The Guardian
- Value of prostate-cancer screening for men between 55 and 69 back under microscope - MarketWatch
- Prostate Conditions Education Council Recognizes the New U.S. Preventative Services Task Force Draft Recommendation for Prostate Cancer Screening — BioPortfolio.com
- Men’s Health Network Encouraged by Latest Prostate Cancer Screening Recommendation from the USPSTF | Mens Health Network
- The new recommendations for prostate cancer screenings are a bad deal
- Us TOO International Responds to New Prostate Cancer PSA Screening Recommendation from USPSTF — BioPortfolio.com
- Discuss Prostate Screening With Your Doctor, Experts Now Say - The New York Times
- Doctors largely defy federal standards on mammograms, prostate cancer screenings - The San Diego Union-Tribune
- At what age should you get screened for prostate cancer? | Genetic Literacy Project
- Italian-style coffee could halve the risk of prostate cancer - Medical News Today
- Should Prostate Cancer Screening Start Earlier for Black Men?
- Recent PSA Testing Patterns in US Screening for Prostate Cancer | Cancer Biomarkers | JAMA Internal Medicine | The JAMA Network
Biopsies and Pathology
is it in there, and if so, what kind of cancer is it:- Take a Stand When Grading Prostate Tumors, Researchers Say
- Access : Prognostic value of the new Grade Groups in Prostate Cancer: a multi-institutional European validation study : Prostate Cancer and Prostatic Diseases
- Access : The prostate cancer prevention trial risk calculator 2.0 performs equally for standard biopsy and MRI|[sol]|US fusion-guided biopsy : Prostate Cancer and Prostatic Diseases
- Additional benefit of using a risk based selection for prostate biopsy: an analysis of biopsy complications in the Rotterdam section of the European Randomized Study of Screening for Prostate Cancer (ERSPC) - Chiu - 2017 - BJU International - Wiley Online Library
- SelectMDx for Prostate Cancer Guides Patient Selection for mpMRI — BioPortfolio.com
- Access : Magnetic resonance imaging targeted transperineal prostate biopsy: a local anaesthetic approach : Prostate Cancer and Prostatic Diseases
Genomics
- Prospective Oncotype DX® Genomic Prostate Score™ Test Data Presented at AUA and Published in Urology Establish Test's Ability to Increase Use and Persistence on Active Surveillance in Prostate Cancer Patients — BioPortfolio.com
- Prostate Cancer and Prostatic Diseases - Utilization of biopsy-based genomic classifier to predict distant metastasis after definitive radiation and short-course ADT for intermediate and high-risk prostate cancer
- Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study | Annals of Oncology | Oxford Academic
- Genomic Markers + Active Surveillance – Prostatepedia
- Computational Personal Genomics: Making Sense of Complete Genomes | Electrical Engineering and Computer Science | MIT OpenCourseWare
Tests
- Test Detects Prostate Cancer 'Smell' Just Like Trained Dog
- New blood test predicts who will benefit from targeted prostate cancer treatments - Medical News Today
- Prostate cancer: Blood test could help target treatment - BBC News
- Experimental blood test predicts advanced prostate cancer outcome | Cancer Research UK
Imaging
- Access : Does mpMRI improve clinical criteria in selecting men with prostate cancer for active surveillance|[quest]| : Prostate Cancer and Prostatic Diseases
- Access : Magnetic resonance imaging targeted transperineal prostate biopsy: a local anaesthetic approach : Prostate Cancer and Prostatic Diseases
Treatment
- AUA, ASTRO and SUO Release New Clinical Guideline on Standard of Care for Men with Localized Prostate Cancer — BioPortfolio.com
- Bicalutamide and Raloxifene Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery
- Low Risk Prostate Cancer Treatment Comparison Favors Robotic Prostatectomy Over Brachytherapy — BioPortfolio.com
- Access : The survival impact of neoadjuvant hormonal therapy before radical prostatectomy for treatment of high-risk prostate cancer : Prostate Cancer and Prostatic Diseases
- Comparative effectiveness of prostate cancer treatments for patient-centered outcomes: A systematic review and meta-analysis (PRISMA Compliant).
Active Surveillance AS
- The Men's Eating and Living (MEAL) Study (CALGB 70807 [Alliance]): Recruitment Feasibility and Baseline Demographics of a Randomized Trial of Diet in Men on Active Surveillance for Prostate Cancer - Parsons - 2017 - BJU International - Wiley Online Library
- Access : Does mpMRI improve clinical criteria in selecting men with prostate cancer for active surveillance|[quest]| : Prostate Cancer and Prostatic Diseases
- Don't Hesitate to Watch Prostate Cancer in Young Men
- Prostate Cancer Surveillance Yields Good Results in Younger Patients | Cancer Network
Surgery RP
frequently the first choice for localized PCa, robotic assist dominates:- Patient Reported Outcome (PRO) questionnaires for men who have radical surgery for prostate cancer: a conceptual review of existing instruments - Protopapa - 2017 - BJU International - Wiley Online Library
- Impact of preoperative risk on metastatic progression and cancer specific death in patients with adverse pathology at radical prostatectomy - Boehm - 2017 - BJU International - Wiley Online Library
Radiation RT
- Giving A Single, High Dose of Radiation Directly to the Site of A Prostate Tumor Is Safe | Cooking with Kathy Man
- Prostate Cancer Patients Satisfed With HDR Brachytherapy
- IsoRay Announces Study Accepted for Publication in The International Journal of Radiation Oncology, Biology, Physics entitled "Long-term Quality of Life in Prostate Cancer Patients Treated with Cesium-131" — BioPortfolio.com
- Access : Lutetium-177-labelled anti-prostate-specific membrane antigen antibody and ligands for the treatment of metastatic castrate-resistant prostate cancer: a systematic review and meta-analysis : Prostate Cancer and Prostatic Diseases
- Access : Establishing the distribution of satellite lesions in intermediate- and high-risk prostate cancer: implications for focused radiotherapy : Prostate Cancer and Prostatic Diseases
- Access : End-of-radiation PSA as a novel prognostic factor in patients undergoing definitive radiation and androgen deprivation therapy for prostate cancer : Prostate Cancer and Prostatic Diseases
Hormone ADT
- Bone health in the prostate cancer patient receiving androgen deprivation therapy: a review of present and future management options
- A comprehensive bone-health management approach for men with prostate cancer receiving androgen deprivation therapy
- Access : The impact of comorbidity and PSA doubling time on the risk of death in men experiencing PSA failure following radiation therapy with or with androgen deprivation therapy for unfavorable-risk prostate cancer : Prostate Cancer and Prostatic Diseases
Chemo
- Repurposing Metformin as Anticancer Drug: in Advanced Prostate Cancer
- Towards better dose individualisation: metabolic phenotyping to predict cabazitaxel pharmacokinetics in men with prostate cancer.
Immunotherapy
New Techniques
- Research Progress on Treatment of Cancer with Compatibility of Traditional Chinese Medicine — BioPortfolio.com
- Dr Xinping Song Seeking Investors to Promote His 3D Prostate Targeted Treatment Globally — BioPortfolio.com
Side Effects
- Comorbidity assessment in localized prostate cancer: a systematic review protocol.
- Assessment of QoL and Outcomes With SBRT for RCC
- What Prostate Cancer Survivors Need to Know about Osteoporosis
- Prostate Cancer and Prostatic Diseases - Lifestyle guidelines for managing adverse effects on bone health and body composition in men treated with androgen deprivation therapy for prostate cancer: an update
- Kaiser reports on quality of life outcomes after first-line treatment for prostate cancer | THE "NEW" PROSTATE CANCER INFOLINK
- The Efficacy and Safety of Udenafil in Patients With Erectile Dysfunction After Bilateral Nerve-sparing Radical Prostatectomy
Advanced/Recurrence
- Managing bone health in men with metastatic prostate cancer | Urology Times
- EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer - European Urology
- CHD1, a new treatment biomarker for recombination deficiency in castration resistant prostate cancer?
- Prostate Cancer and Prostatic Diseases - Radiographic progression with nonrising PSA in metastatic castration-resistant prostate cancer: post hoc analysis of PREVAIL
- Dendreon Announces Results of New PROCEED Registry Analysis Showing Overall Survival Benefit with PROVENGE® in Men with Metastatic Prostate Cancer — BioPortfolio.com
- Prostate Cancer Outcomes: An International Registry to Improve Outcomes in Men With Advanced Prostate Cancer (IRONMAN)
- Randomized Phase II Study of Salvage XRT + ADT +/- Abiraterone and Apalutamide for Rising PSA After RP
No comments:
Post a Comment